Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., Derksen R. H., De Groot P. G., Koike T., Meroni P. L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P. G., Krilis S. A., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J. THROMB. HAEMOST., 4(2), 295-306, 2006.
Asherson R. A., Cervera R., De Groot P. G., Erkan D., Boffa M. C, Piette J. C, Khamashta M. A., Shoenfeld Y.; Catastrophic Antiphospholipid Syndrome Registry Project Group, Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, LUPUS, 12, 530-4, 2003.
Houssiau F. A., Vasconcelos C, D'Cruz D., Sebastiani G. D., De Ramon Garrido E., Danieli M. G., Abramovicz D., Blockmans D., Cauli A., Direskeneli H., Galeazzi M., Güi A., Levy Y., Petera P., Popovic R., Petrovic R., Sinico R. A., Cattaneo R., Font J., Depresseux G., Cosyns J. P., Cervera R., The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide, ANN. RHEUM. DIS., 69(1), 61-4, 2010.
Asherson R. A., The catastrophic antiphospholipid syndrome, J. RHEUMATOL., 19, 508-12, 1992.
Cervera R., Bucciarelli S., Plasfn M. A., Gomez-Puerta J. A., Plaza J., Pons-Estel G., Shoenfeld Y., Ingelmo M., Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies), Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry", J. AUTOIMMUN., 32, 240-5, 2009.
Cervera R.; CAPS Registry Project Group, Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry', LUPUS, 19, 412-8, 2010.
Erkan D., Espinosa G., Cervera R., Catastrophic antiphospholipid syndrome: updated diagnostic algorithms, AUTOIMMUN. REV., 10, 74-9, 2010.
Cervera R., Font J., Gómez-Puerta J. A., Espinosa G., Cucho M., Bucciarelli S., Ramos-Casals M, Ingelmo M., Piette J. C, Shoenfeld Y., Asherson R. A.; Catastrophic Antiphospholipid Syndrome Registry Project Group, Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome, ANN. RHEUM. DIS., 64, 1205-9, 2005.
Cervera R., Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome, CURR. RHEUMATOL. REP., 12, 70-6, 2010.
Pasquali J. L., Sibilia J., Poindron V., Korganow A. S., Soulas-Sprauel P., Martin T., [Immunological aspects of the antiphospholipid syndrome]. REV. MED. INTERNE, 33(4), 189-93, 2012.
Nochy D., Daugas E., Droz D., Beaufils H., Griinfeld J. P., Piette J. C, Bariety J., Hill G., The intrarenal vascular lesions associated with primary antiphospholipid syndrome, J. AM. SOC. NEPHROL., 10, 507-18, 1999.
Bucciarelli S., Cervera R., Espinosa G., Gómez-Puerta J. A., Ramos-Casals M., Font J., Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors, AUTOIMMUN. REV., 6, 72-5, 2006.
Uthman I. W., Khamashta M. A., Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome, J. RHEUMATOL., 33(12), 2379-82, 2006.
Desailloud R., Papo T., Vaneecloo S., Gamblin C, Vanhille P., Piette J. C, Acalculous ischemic gallbladder necrosis in the catastrophic antiphospholipid syndrome, ARTHRITIS. RHEUM., 41, 1318-20, 1998.
Papo T., Le Thi Huong D., Godeau P., Piette J. C, [Pancreatitis and systemic diseases], GASTROENTEROL. CLIN. BIOL., 768-75, 1997.
Okano K., Oshima M., Kakinoki K., Dobashi H., Suzuki Y., Catastrophic antiphospholipid syndrome presenting with a splenic rupture, SURGERY, 150(5), 1012-4, 2011.
Pengo V., Tripodi A., Reber G., Rand J. H., Ortel T. L., Galli M., De Groot P. G., Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant! Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis, J. THROMB. HAEMOST., 7(10), 1737-40, 2009.
Amoura Z., Costedoat-Chalumeau N., Veyradier A., Wolf M., Ghillani-Dalbin P., Cacoub P., Meyer D., Piette J. C, Thrombotic thrombocytopenic purpura with severe adamts-13 deficiency in two patients with primary antiphospholipid syndrome, ARTHRITIS RHEUM., 50, 3260-4, 2004.
Lasne D., Saffroy R., Bachelot C, Vincenot A., Rendu F., Papo T., Aiach M., Piette J. C, Tests for heparin-induced thrombocytopenia in antiphospholipid syndrome, BR. J. HAEMATOL., 97, 939, 1997.
Avcin T., Toplak N., Antiphospholipid antibodies in response to infection, CURR. RHEUMATOL. REP., 9, 212-8, 2007.
Wenzel C, Stoiser B., Locker G. J., Laczika K., Quehenberger P., Kapiotis S., Frass M., Pabinger I., Knöbl P., Frequent development of lupus anticoagulants in critically ill patients, CRIT. CARE MED., 30, 763-70, 2002.
Pengo V., Biasiolo A., Gresele P., Marongiu F., Erba N., Veschi F., Ghirarduzzi A., De Candia E., Montaruli B., Testa S., Barcellona D., Tripodi A.; Participating Centres of Italian Federation of Thrombosis Centres (FCSA), Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples, J. THROMB. HAEMOST., 5, 925-30, 2007.
Asherson R. A., Cervera R., Piette J. C, Font J., Lie J. T., Burcoglu A., Lim K., Munoz-Rodriguez F. J., Levy R. A., Boué F., Rossert J., Ingelmo M., Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients, MEDICINE (BALTIMORE), 77, 195-207, 1998.
Bucciarelli S., Espinosa G., Cervera R., The caps registry: Morbidity and mortality of the catastrophic antiphospholipid syndrome. LUPUS, 18, 905-12, 2009.
Cervera R., CAPS registry, LUPUS, 21(7), 755-7, 2012.
Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R., The management of thrombosis in the antiphospholipid-antibody syndrome, N. ENGL. J. MED., 332, 993-7, 1995.
Bortolati M., Marson P., Fabris F., Pengo V., Facchinetti M., De Silvestro G., Ruffatti A., Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure, AUTOIMMUN. REV., 8, 297-301, 2009.
Zar T., Kaplan A. A., Predictable removal of anticardio-lipin antibody by therapeutic plasma exchange (tpe) in CAPS, CLIN. NEPHROL., 70, 77-81, 2008.
Neuwelt CM., Daikh D. I., Linfoot J. A., Pfister D. A., Young R. G., Webb R. L., London S. S., Asherson R. A., Catastrophic antiphospholipid syndrome, ARTHRITIS RHEUM., 40, 1534-9, 1997.
Boura P., Papadopoulos S., Tselios K., Skendros P., Dioritou O., Malamis G., Makris P., Lefkos N., Intracerebral hemorrhage in a patient with sle and catastrophic antiphospholipid syndrome (caps): Report of a case, CLIN. RHEUMATOL., 24, 420-4, 2005.
Bucciarelli S., Espinosa G., Cervera R., Erkan D., Gómez-Puerta J. A., Ramos-Casals M., Font J., Asherson R. A.; European Forum on Antiphospholipid Antibodies, Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients, ARTHRITIS RHEUM., 54(8), 2568-76, 2006.
Bayraktar U. D., Erkan D., Bucciarelli S., Espinosa G., Asherson R.; Catastrophic Antiphospholipid Syndrome Project Group, The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus, J. RHEUMATOL., 34, 346-52, 2007.
Erre G. L., Pardini S., Faedda R., Passiu G., Effect ofritux-imab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature, LUPUS, 17(1), 50-5, 2008.
Espinosa G., Berman H., Cervera R., Management of refractory cases of catastrophic antiphospholipid syndrome, AUTOIMMUN. REV., 10, 664-8, 2011.
Erkan D., Vega J., Ramon G., Kozora E., Lockshin M. D., A pilot open label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome, ARTHRITIS RHEUM., 65(2), 464-71, 2013.
Berman H., Rodríguez-Pintó I., Cervera R., Morel N., Costedoat-Chalumeau N., Erkan D., Shoenfeld Y., Espinosa G.; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies), Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab, AUTOIMMUN. REV., 12(11), 1085-90, 2013.
Lonze B. E., Singer A. L., Montgomery R. A., Eculizumab and renal transplantation in a patient with caps, N. ENGL. J. MED., 362(18), 1744-5, 2010.
